Vor Biopharma VOR Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's short- and long-term operating lease liabilities?
- Vor Biopharma (VOR) reported short- and long-term operating lease liabilities of -$61K in Q1 2026.
- How has Vor Biopharma's short- and long-term operating lease liabilities changed year-over-year?
- Vor Biopharma's short- and long-term operating lease liabilities increased by 94.2% year-over-year, from -$1.05M to -$61K.
- What is the long-term trend for Vor Biopharma's short- and long-term operating lease liabilities?
- Over 4 years (2021 to 2025), Vor Biopharma's short- and long-term operating lease liabilities has grown at a -1.5% compound annual growth rate (CAGR), from -$2.56M to -$2.41M.